Showing results (131-140 of 411) with videos related to
Sort By:
Pageof 42
EMBO Reports|February 19, 2002
Disruption of Brca2 increases the spontaneous mutation rate in vivo: synergism with ionizing radiationAndrew N J Tutt, Conny Th M van Oostrom, Gillian M Ross, et al.The EMBO Journal|May 30, 2003
A subset of ATM- and ATR-dependent phosphorylation events requires the BRCA1 proteinNicolas Foray, Didier Marot, Anastasia Gabriel, et al.Breast Cancer Research : BCR|February 6, 2014
Timing of pubertal stages and breast cancer risk: the Breakthrough Generations StudyDanielle H Bodicoat, Minouk J Schoemaker, Michael E Jones, et al.International Journal of Radiation Biology|November 12, 2010
Gene expression following ionising radiation: identification of biomarkers for dose estimation and prediction of individual responseSylwia Kabacik, Alan Mackay, Narinder Tamber, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 6, 2007
Effect of delays in processing blood samples on measured endogenous plasma sex hormone levels in womenMichael E Jones, Elizabeth J Folkerd, Deborah A Doody, et al.Breast Cancer Research : BCR|April 24, 2009
Pregnancy in the mature adult mouse does not alter the proportion of mammary epithelial stem/progenitor cellsKara L Britt, Howard Kendrick, Joseph L Regan, et al.Breast Cancer Research : BCR|February 13, 2020
Correction to: Timing of pubertal stages and breast cancer risk: the Breakthrough Generations StudyDanielle H Bodicoat, Minouk J Schoemaker, Michael E Jones, et al.American Journal of Epidemiology|April 2, 2014
Reproducibility of estradiol and testosterone levels in postmenopausal women over 5 years: results from the breakthrough generations studyMichael E Jones, Minouk J Schoemaker, Megan Rae, et al.Journal of the National Cancer Institute|July 20, 2006
Inconsistent association between the STK15 F31I genetic polymorphism and breast cancer riskOlivia Fletcher, Nichola Johnson, Claire Palles, et al.EMBO Molecular Medicine|January 6, 2010
Methotrexate induces oxidative DNA damage and is selectively lethal to tumour cells with defects in the DNA mismatch repair gene MSH2Sarah A Martin, Afshan McCarthy, Louise J Barber, et al.Pageof 42